第２回FACO肺癌アカデミック委員会合開催（シンガポール）

 The 2nd FACO Lung Cancer Academic Committee Meeting in Singapore

シンガポールで開催された世界肺癌学会会議の会期中に、光冨徹哉先生が主催し、日中韓のFACO肺癌Academic Committee委員であるProf.Caicun Zhou、Prof. Nan Wu、Dr. Deog Gon Cho、山本信之先生ほか13名が参加し（現地＋virtual)、第２回肺癌アカデミック委員会合を開催。

FACO肺癌グループとして最初に取り組む国際共同研究のテーマに関しコンセンサスを得ました。

During the World Conference on Lung Cancer (IASLC/WCLC 2023) held in Singapore, hosted by Prof. Tetsuya Mitsutomi, members of the Japan-China-Korea FACO Lung Cancer Academic Committee, Prof. Caicun Zhou, Prof. Nan Wu, Prof. Deog Gon ChoProf, Prof. Nobuyuki Yamamoto and 13 other members participated (local + virtual) in the 2nd FACO Lung Cancer Academic Committee Meeting.

A consensus was reached regarding the theme of the first international collaborative research undertaken by the FACO Lung Cancer Group.

第11回FACO学術集会

 The 11th International Conference of FACO in conjunction with KSMO2023 Congress

2023年9月8日、韓国Grand Walkerhill Seoulにおいて、第16回KSMO学術集会（KSMO2023）に併催し、第11回FACO学術集会が開催されました。

FACOセッションは、「大腸癌」および「臨床研究」の２つのテーマで日中韓の研究者がディスカッションし、日本からの演者は西山正彦先生（司会）、沖英次先生（演者）、藤原恵一先生（演者）が参加。

同じ日、第22回FACOビジネス会合も開催し、今後のFACOの方針に関して話し合いが行われました。

The 11th International Conference of FACO was held in conjunction with KSMO2023 Congress at Grand Walkehill Seoul in Korea on 8th September 2023. The same day, the 22nd FACO Business Meeting was held with doctors from three counties.

FACO Session 1：Recent updates in colorectal cancer treatment

Chairs：

Jin Li (FACO Chairman, China)

Young Suk Park (Samsung Medical Center, Republic of Korea)

Speakers:

1. Recent progress in neoadjuvant treatment for locally advanced rectal cancer

Sun Young Kim (Asan Medical Center, Republic of Korea)

2. Does checkpoint inhibitor work in microstallite stable mCRC patients?

Ying Yuan (The Second Affiliated Hospital Zhejiang University School of Medicine, China)

3. Beyond the scalpel: Advancing colorectal cancer management through ctDNA liquid biopsy

Eiji Oki (Kyushu University, Japan)

FACO Session 2: Proposals for new FACO clinical trials

Chairs: 

Masahiko Nishiyama (FACO CEO, Higashi Sapporo Hospital, Japan)

Dong-Wan Kim (Seoul National University Hospital, Republic of Korea)

Speakers:

1. Clinical trials: from the viewpoint of lung cancer medical oncologist

Sehhoon Park (Samsung Medical Center, Republic of Korea)

2. Clinical trials: From the viewpoint of a gynecologic oncologist

Ning Li (National Cancer Center/Cancer Hospital (Institute) Chinese Academy of Medical Sciences & Peking Union Medical College, China)

3. International Collaboration in Gynecological Cancer Trials

Keiichi Fujiwara (Saitama Medical University and International University of Health and Welfare, Japan)

第1回FACO肺癌Academic Committee会合

 The 1st FACO Lung Cancer Academic Committee Meeting 

FACOでは、胃癌・乳癌・膵癌の試験を日中韓で行ってきましたが、次の国際試験の療育として、肺癌が候補となっています。

光冨徹哉先生が中心となり、日中韓の研究者たちが第1回会合をZoomにて開催しました。

FACO has conducted clinical trials for gastric, breast, and pancreatic cancer with the collaboration of China, Japan and Korea, and lung cancer is now a candidate for the next international trial.

Led by Dr. Tetsuya Mitsutomi, investigators from China, Japan, Korea held the first meeting at Zoom.

PC-CURE-1 第109回日本消化器病学会総会での発表

 PC-CURE-1, presentation at the 109th General Meeting of the Japanese Society of Gastroenterology

2023年4月６日～８日、長崎の出島で開催された第109回日本消化器病学会総会の二日目・7日に、PC-CURE-1の追加解析を含めた結果が主題演題に採択され、がん研有明病院の井上陽介先生が「消化器がんのコンバージョン治療戦略」として、プレゼンテーションを行いました。

The 109th General Meeting of the Japanese Society of Gastroenterology was held from 6th to 8th April 2023 in Dejima, Nagasaki. Dr. Yosuke Inoue from the Cancer Institute Hospital Of JFCR gave a presentation on PC-CURE-1 during the Workshop No.5 "Conversion Treatment Strategy for Gastrointestinal Cancer".

臨床研究のリスタートに向け理事会を開催

 Face-to-face Board Meeting for the new step for FACO

コロナ渦で中断されていたFACOの新しい臨床研究の着手にむけ、

呼吸器と婦人科領域のエキスパートを新しい理事にむかえ、

理事会を開催しました。

当日のお弁当。

Toward the start of FACO's new clinical trial, which has been suspended due to the COVID-19, expert doctors in lung cancer and gynecological cancer have been joining as a new board member from January 2023, and the face-to-face board meeting was held in Tokyo.

OLIGO-BC1研究「Breast Cancer」誌に掲載

 OLIGO-BC1 has been published at Breast Cancer

井本滋先生がPIをつとめる乳腺研究のOLIGO-BC1論文が「Breast Cancer」誌に掲載されました。

The academic paper of OLIGO-BC1 has been published at Breast Cancer.